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Compelling nature of arterial manifestations in
Behçet disease
Zafer H. Iscan, MD, Kerem M. Vural, MD, and Murat Bayazit, MD, Ankara, Turkey
Introduction: We present our experience with surgical treatment of arterial complications in Behçet disease (vasculo-
Behcet disease), and the long-term results and pitfalls of surgical treatment.
Material and methods: Between January 1990 and January 2003, 20 consecutive patients underwent surgery to treat
vasculo-Behcet disease. Most patients (17 of 20) were men, with mean age of 38.4 years.
Results: Thirty-four operations were performed in 20 patients. The operative mortality rate was 5.8% (2 patients). There
were 17 emergency operations, 6 because of ruptured primary abdominal aneurysms. There were five others with critical
limb ischemia, resulting in 3 amputations. All patients were followed up postoperatively on average for 44 months (range,
6 months-14 years). Two additional patients were lost to follow-up. After the initial operation 10-year survival rate was
30%, 10-year complication-free survival rate was 13%, and 5-year repeat operation–free survival rate was 26%.
Conclusion: Although surgical intervention should be postponed until active inflammation has subsided, often this is not
possible, because of the emergent nature of these problems. Most arterial complications of vasculo-Behcet disease present
with a pseudoaneurysm rupture or with impending rupture. An aggressive surgical approach can be life-saving in such
instances, and should be undertaken regardless of long-term complications, which are more common when the operation
is performed in the presence of active inflammation. Early and late results can be improved by individualizing, selecting
a disease-free area for reconstruction, and eliminating use of autologous graft material. ( J Vasc Surg 2005;41:53-8.)Behçet disease, originally described by Hulusi Behçet
in 1937, is a chronic relapsing inflammatory process of
unknown cause or an immunologic syndrome. It develops
in the third and fourth decades of life, and is prevalent in
Mediterranean countries, the Middle East, and Eastern
Asia.1-6 Although characterized by a classic triad of urogen-
ital ulcerations, chronic eye inflammation, and skin lesions,
it is a multiple-system disease, and prognosis is determined
by involvement of the cardiovascular, gastrointestinal, and
central nervous systems.
Vascular complications (vasculo-Behcet disease), noted
in 7% to 29% of patients,2 gravely affect the course of the
disease. Vascular lesions are most likely to involve the
venous system; however, arterial lesions are the greater risk.
Involvement of a major artery is seen in 1.5% to 2.2% of
patients,2,7 often in the form of a rapidly expanding aneu-
rysm.
The results of surgical therapy are adversely influenced
by the systemic inflammatory nature of the disease, and
serious problems such as repeated graft occlusions or pseu-
doaneurysm formation are frequently encountered.
We present a review of our experience with surgical
treatment of arterial complications of Behçet disease, and
long-term results, and emphasize the pitfalls of surgery.
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doi:10.1016/j.jvs.2004.09.018MATERIAL AND METHODS
Between January 1990 and January 2003, 20 consecu-
tive Turkish patients were referred from other institutions
for surgical treatment of vascular manifestations of Behçet
disease. Most patients were male (17 of 20), with mean age
of 38.4 years (range, 26-53 years). Patient data are summa-
rized in Table I. Patients with isolated cardiac or venous
involvement were not included in this series. Only those
patients admitted with arterial complications were included
in the study.
The incidence of the components of the classic Behçet
triad (aphthous stomatitis, urogenital ulcerations, uveitis) is
depicted in Fig 1. The most frequent symptom was visceral
pain, other abdominal pain, or discomfort that was dif-
ficult to localize, noted in 35.3% of patients (n  12;
Table II).
Hypertension, in 40% of patients (n 8) was the most
frequent associated disease. Elevation in inflammatory
markers (erythrocyte sedimentation rate, serum fibrinogen
concentration, C-reactive protein, white blood cell count)
was noted in most patients (Table III).
Vascular manifestations are depicted in Table IV. It was
not possible to determine the exact duration of arterial
involvement in each patient, inasmuch as all were referred
from other institutions, where the diagnosis was made and
patients were followed up. Thirty-four operations were
performed in 20 patients. Fourteen were repeat operations
to treat complications, 17 were emergency operations, and
6 were performed to treat ruptured abdominal aneurysms.
There were 5 others with critical limb ischemia, resulting in
3 amputations. Most patients had aortic (thoracic or ab-
dominal), visceral, peripheral, or carotid artery aneurysms
(Table I).
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infrarenal). All were rapidly progressive, with impending
rupture. Six had ruptured at admission, and emergency
surgery as performed. The average interval from the diag-
nosis of Behçet disease to surgical treatment was 45
months. All patients were followed up on average for 44
months (range, 6 months-14 years) after initial operation.
The mean period between initial operation and first post-
operative vascular complication was 44 months (range,
2-13 years).
The diagnosis of Behçet disease was established in all
Table I. Patient data
Patient Sex
Age
(y)
Components
of Behçet
triad
Duration
of Behçet
(mo)
1 F 30 AS,GU 5 I
2 M 45 AS 84 R
3 M 28 AS,U,GU 48 I
4 M 39 AS,U,GU 144 I
5 F 33 AS,GU 32 I
6 M 42 AS 60 R
7 M 37 AS,GU 120 R
8 M 39 AS,GU 96 I
9 F 42 AS,GU 36 R
10 M 33 AS,GU 56 R
11 M 48 AS,GU 96 R
12 M 26 AS,GU 18 A
13 M 33 AS,GU 92 T
14 M 43 AS 48 I
15 M 35 AS,GU 72 C
16 M 48 AS,GU 108 L
17 M 30 AS,U,GU 120 R
18 M 41 AS,U,GU 48 R
19 M 42 AS, GU 120 R
20 M 53 AS, UGU 144 T
AS, Aphthous stomatitis; GU, urogenital ulcerations; U, uveitis; AAA, abd
Fig 1. Frequency of components of classic triad of Behçet’s clin-
ical manifestations, as originally described. Numbers in intersec-
tion areas of circles represent number of patients manifesting any
combination of these components.patients at other institutions. If in the course of follow-upvascular complications developed, the patients were re-
ferred to our institution.
Surgical strategy. Although our policy is to delay
surgery in these patients until after an exacerbation sub-
sides, this was seldom possible. The emergent nature of the
situation did not permit waiting for a safe period in most
cases. Consequently, 9 patients underwent emergency
operation because of aneurysm rupture or critical isch-
emia.
Reconstruction was always attempted in a disease-free
appearing segment of artery. In an effort to avert suture line
difficulties or pseudoaneurysm formation, the suture line
was reinforced with Teflon pledgets and the graft was
wrapped with omentum. We believe that the choice of graft
material is also an important factor in decreasing the long-
term risk for complications. Because vasculitis might be
present in venous tissue, avoiding use of autologous grafts,
and use of synthetic material instead, seemed prudent. The
graft material used was Dacron (Hemashield) in all abdom-
Vascular manifestation Follow-up (mo)
enal AAA (8  6 cm) 15
red infrarenal AAA (5  4.5 cm) Early mortality
enal AAA (5  5 cm) 59
enal AAA (6  7 cm) 162
enal AAA (10  12 cm) 90, late mortality
red infrarenal AAA (8  6.5 cm) 36
red infrarenal AAA (6  5 cm) 67, late mortality
enal AAA (6  6 cm) 24
red infrarenal AAA (7  7 cm) 55
red infrarenal AAA (8  7 cm) Early mortality
red infrarenal AAA (5  6 cm) 48
den-arcus and infrarenal AAA 14
coabdominal artery aneurysm (6  7 cm) 12
al carotid artery aneurysm (7  7 cm) 35
and left subclavian artery aneurysm 43
opliteal artery aneurysm (10  8 cm) 14
femoral and left popliteal artery
urysm (5  4 cm)
6
femoral artery aneurysm (5  6 cm) 24
femoropopliteal occlusion 3
coabdominal artery aneurysm (6  5 cm) 11
l aortic aneurysm.
Table II. Symptoms in patients admitted with vasculo-
Behçet disease
Symptom
No. of
patients
Percent of
patients
Visceral pain, abdominal discomfort 12 35.3
Back pain 8 23.5
Extremity pain 6 17.7
Precordial chest pain 1 2.9
Cervical pain 1 2.9
Cervical mass 1 2.9nfrar
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in Table IV.
Venous manifestations in present series. Although
venous manifestations were beyond the scope of the study,
in brief, these were recurrent deep vein thrombosis, super-
ficial thrombophlebitis, and veno-occlusive disease. Four
Table III. Incidence of inflammatory markers
Percent
Accelerated ESR 52.9
Elevated fibrinogen level 17.6
Elevated CRP 44.1
Increased WBC 29.4
Inflammatory markers in patients with ruptured vs nonruptured a
ESR (average)
Serum fibrinogen level (average)
CRP (average-fold increase)
WBC (average)
ESR, Erythrocyte sedimentation rate; CRP, C-reactive protein; WBC, whit
Table IV. Diagnosis, surgical procedures, and inflammato
Patient Diagnosis
1 Infrarenal AAA Tu
1 Limb ischemia Em
1 Limb ischemia Em
2 Ruptured infrarenal AAA Bif
3 Infrarenal AAA Bif
3 Ruptured infrarenal AAA Re
4 Infrarenal AAA Bif
4 Graft thrombosis Re
4 Limb ischemia Rig
5 I AAA Bif
5 Right pulmonary artery aneurysm Lo
5 Graft thrombosis Re
5 Limb ischemia, graft infection Am
6 Ruptured infrarenal AAA Tu
7 Ruptured infrarenal AAA Tu
7 Aortoduodenal fistula Re
7 Pseudoaneurysm rupture Th
8 Infrarenal AAA Tu
9 Ruptured infrarenal AAA Tu
9 Acute type 1 dissection Va
10 Ruptured infrarenal AAA Ao
10 I˙schemic bowel Ha
11 Ruptured infrarenal AAA Ao
12 Ascending, arcus artery aneurysm Tu
12 Infrarenal AAA Tu
13 Thoracoabdominal artery aneurysm Tu
14 Internal carotid artery aneurysm PT
15 Celiac and left subclavian artery
aneurysm
PT
16 Left popliteal artery aneurysm PT
17 Right femoral and left popliteal
artery aneurysm
PT
17 Limb ischemia Em
18 Right femoral artery aneurysm PT
19 Left femoral occlusion Tu
20 Thoracoabdominal artery aneurysm Tu
ESR, Erythrocyte sedimentation rate (s); WBC, white blood cell count (pe
available.patients had venous system involvement: acute lower ex-tremity thrombophlebitis and inferior vena cava thrombo-
sis in 1 patient each, and deep venous thrombosis in 2
patients.
RESULTS
Thirty-four operations were performed in 20 patients.
Ruptured Nonruptured P
sms
63  31 44  14 NS
7.00  1.2 6.65  2.1 NS
2.7  0.6 2.3  0.6 NS
13,900  3500 13,600  3200 NS
d cell count; NS, not significant.
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critical limb ischemia, with amputation in 3. There were 2
operative deaths (mortality rate, 5.8%). In both instances,
an emergency operation had been performed to treat a
ruptured aneurysm. (Table IV).
There were 25 operations for treatment of primary or
secondary aneurysms, performed in 19 patients. Eight were
emergency operations to treat rupture (6 primary ruptures,
2 postoperative pseudoaneurysm ruptures).
There were 9 operations for treatment of occlusions or
ischemia, performed in 6 patients. Only 1 of these patients
had primary occlusive vasculo-Behçet disease, due to in-
flammatory vasculitis. The remaining 5 patients had previ-
ously been operated on to treat aneurysmal disease, and the
cause of ischemia in these patients was either graft occlusion
or native limb vessel occlusion after the aneurysm repair.
Five of these operations were undertaken emergently, be-
cause of critical limb ischemia, ending in amputation in 3
patients (see Table IV).
At operation, all aneurysms appeared to be pseudoan-
eurysms, protruding from variable-sized and smooth-
edged ulcerations on the inflamed arterial wall. These an-
eurysms were surrounded by an inflammatory reaction in
adjacent tissues that were difficult to dissect. This made
control of the artery both difficult and hazardous. His-
topathologic analysis of removed tissue revealed inflamma-
tory arteritis, with typical characteristics of leukocytoclastic
arteritis associated with ulceration and perforation of the
arterial wall.
All patients were followed up postoperatively on aver-
age for 44 months (range, 6 months-14 years). Two pa-
tients were lost to extended follow-up: 1 died of sepsis and
Fig 2. Anastomotic pseudoaneurysm developed 5 months after
successful graft interposition.multiple organ failure at postoperative month 90, and 1patient died of a ruptured pulmonary artery aneurysm at
postoperative month 67.
All other deaths were related to vascular system involve-
ment (vasculo-Behçet disease): 6 due to primary pseudo-
aneurysm ruptures, 2 due to anastomotic pseudoaneurysm
rupture (Fig 2), 2 due to pseudoaneurysms arising from an
angiography puncture site, 9 due to graft thromboses and
occlusion, and 2 due to distant vascular complications in
patients with a pulmonary artery aneurysm at presentation.
In 1 patient a 6  5-cm infrarenal abdominal aortic aneu-
rysm developed over 12 months, and in another patient a
7  7-cm extracranial internal carotid artery aneurysm
developed over 3 months. This rapid aneurysm formation
and the 6 primary aneurysm ruptures illustrate the rapidly
progressive nature of vasculo-Behçet pseudoaneurysms.
One aortoduodenal fistula with hematemesis and melena
was noted at postoperative month 18.
We treated 3 postoperative graft thromboses with crit-
ical limb ischemia resulting in 2 lower extremity amputa-
tions. Another patient underwent lower extremity amputa-
tion because of persistent graft infection.
In 1 patient a right pulmonary artery branch aneurysm
(5  5 cm) noted during the sixth year of follow-up was
treated with pulmonary lobectomy. The patient underwent
a repeat operation because of graft occlusion in the same
year. She died 2 years later of graft sepsis and multiple organ
failure.
After the initial operation, 10-year survival rate (includ-
ing operative mortality) was 30%, 10-year complication-
free survival rate was 13%, and 5-year repeat operation–free
survival rate was 26% (Figs 3 to 5).
DISCUSSION
When arterial involvement occurs in Behçet disease, it
drastically alters the course of the disease and is associated
with a poor prognosis. Surgical intervention in the active
inflammatory phase is associated with major difficulties,
including suture line dehiscence, pseudoaneurysm forma-
tion, aortoenteric fistula, graft occlusion, and thromboem-
Fig 3. Survival after vascular manifestation, including early hos-
pital mortality.bolic events.
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distal emboli and limb-threatening ischemia. These com-
plications probably are related to the inflammatory nature
of the disease, and are a challenge for the vascular
surgeon.4-6,8-10 The main pathologic finding is large vessel
(eg, iliac, femoral, popliteal arteries) thrombosis or graft
occlusion due to inflammatory vasculitis, hypercoagulabil-
ity, and fibrinogen elevation. However, small vessel in-
volvement with resultant tissue necrosis, and repetitive
distal microembolism also occur as a result of the same
pathologic conditions (inflammatory vasculitis, hyperco-
agulability). This probably results in poor distal runoff.
The interval from diagnosis of Behçet disease to mani-
festation of arterial involvement is difficult to determine,
and varies among patients. Nevertheless, once vascular
disease develops, progression to aneurysm formation and
subsequent rupture can be rapid. Aneurysm rupture is the
most common cause of death.
Arterial complications occur in 1.2% to 2.2% of
patients,2,7 aneurysm in 65% of patients, and occlusion in
35% of patients.11 Pulmonary artery involvement is not
uncommon , and can result in massive and potentially fatal
hemoptysis,12-15 as occurred in 2 patients in this series.
In our experience, the primary arterial lesion is usually a
pseudoaneurysm or fistula. We noted pseudoaneurysm for-
mation at the anastomosis and at an angiographic puncture
site. The ulcerations in the inflamed arterial wall observed at
operation and through which pseudoaneurysms protruded
resembled those seen in mucocutaneous membranes and
genitalia. Histologic examination of arterial specimens re-
vealed leukocytoclastic arteritis, possibly responsible for
ulceration and perforation of the arterial wall, and could
explain why rupture is so common in these aneurysms
despite their relatively small size compared with atheroscle-
rotic aneurysms.
Behçet disease–related aneurysms represented 2.9% of
all surgically treated abdominal aneurysms in our institu-
Fig 4. Major arterial complication-free survival.tion during the study period. This small percentage of ourtotal operative aneurysm experience far more often re-
quired an urgent or emergent procedure, and was associ-
ated with greater morbidity and mortality. In view of these
somber observations, we can conclude that this disease is a
major health problem in areas where it is prevalent.
SUMMARY
Behçet disease aneurysm is a major challenge, be-
cause of its rarity and lack of a specific diagnostic test.
The surgical approach differs significantly from that used
for atherosclerotic aneurysm, because of their unusual
behavior. A high index of suspicion should be main-
tained, especially in young men admitted with Behçet’s
triad, obscure visceral pain, and an aneurysm that is
atypical in location or behavior.
Patients with a diagnosis of Behçet disease should be
screened for multiple silent aneurysms, followed up at close
intervals, and screened after a major activation phase. For
this purpose, duplex ultrasound scanning, contrast material–
enhanced computed tomography, or magnetic resonance im-
aging is more appropriate than angiography, inasmuch as
angiography can be associated with pseudoaneurysm at the
puncture site.
Patients with acute exacerbation are susceptible to ar-
terial wall necrosis and perforation, and therefore control of
such episodes is of utmost importance.
Patients operated on during exacerbation of the
acute inflammatory process are at great risk for postop-
erative complications, such as graft dehiscence and
thrombosis. We recommend waiting until the active
inflammation subsides, and performing the vascular re-
construction during a period of remission. If operation
can be postponed, anti-inflammatory medical treatment
should be initiated. The course of the disease can be
monitored by observing a decrease in erythrocyte sedi-
mentation rate. While this may be appropriate in some
patients with thromboembolic manifestations, the pres-
ence of an aneurysm should mandate urgent surgical
intervention, even for a small asymptomatic aneurysm,
Fig 5. Repeat operation–free survival.because these pseudoaneurysms have an alarming ten-
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ture in 2 aneurysms smaller than 5 cm in diameter.
Because perivascular inflammation and vasculitis can
involve an autologous saphenous vein, we prefer using
synthetic graft material. It is important to choose an area
that appears free of disease for the reconstruction, and to
stay as far as possible from the diseased arterial segment.
Wrapping the graft in an omental flap may be useful to
avoid duodenal adherence and dead space complications.
Inasmuch as the vessel wall is inflamed tissue, it should be
removed and not used for wrapping the graft.
Good control of exacerbations may be helpful to ensure
long-term complication-free survival. The efficacy of sys-
temic immunosuppressive drugs such as cyclophosphamide
or steroids in controlling the intense arterial wall inflamma-
tion has been studied16; however, the beneficial effects of
immunotherapy remain controversial. These drugs have
serious side effects. They can increase susceptibility to
infection; delay wound healing; distort collagen synthesis,
deposition, or remodeling; and may exacerbate the destruc-
tion process in the vessel wall.17 One patient had aseptic
necrosis of the femur after steroid treatment. Defective
fibrinolysis and high serum fibrinogen levels may contrib-
ute to the tendency for intravascular thrombosis. There-
fore, antiplatelet therapy is a routine part of our postoper-
ative management.
CONCLUSION
A timely, aggressive surgical approach to vasculo-
Behçet disease is life saving in many instances. The early and
late results of operation can be improved by individualizing
the procedure, selecting a disease-free area for reconstruc-
tion, and avoiding the use of autologous graft material.
However, despite all efforts, once vascular involvement
occurs, the prognosis with Behçet disease significantly
worsens. The outcome after surgical intervention is ad-
versely influenced by complications unique to the severe
inflammatory nature of this disease. Endovascular treat-
ment techniques may be a potential option in the manage-
ment of these patients in the future.14,18
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